Ad
GSK Short Information GlaxoSmithKline PLC
Short Information | GlaxoSmithKline PLC (NYSE:GSK)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 754,522 |
| Total Actual Volume | 100,124,154 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 37,726 |
| Average Short Percentage | 0.76% |
Is there a GSK Short Squeeze or Breakout about to happen?
See the GSK Short Analysis for free Sign up or Login
Powered by Squeeze Report
GSK Twenty Trading Day's Volume to Short Volume Chart
GSK Twenty Trading Day Price Chart
GSK Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-20-2025 | $38.72 | $38.07 | $38.72 | $37.815 | 8,216,399 | 45,817 | 0.56% |
| 06-18-2025 | $39.47 | $38.64 | $39.52 | $38.58 | 8,171,577 | 39,561 | 0.48% |
| 06-17-2025 | $40.2 | $39.72 | $40.39 | $39.6437 | 4,685,472 | 38,492 | 0.82% |
| 06-16-2025 | $40.93 | $40.49 | $41.105 | $40.355 | 4,651,855 | 11,627 | 0.25% |
| 06-13-2025 | $41.62 | $40.86 | $41.93 | $40.81 | 7,658,807 | 98,804 | 1.29% |
| 06-12-2025 | $42.21 | $42.49 | $42.63 | $42.09 | 3,558,863 | 14,379 | 0.4% |
| 06-11-2025 | $41.35 | $41.62 | $41.755 | $41.32 | 4,494,382 | 31,721 | 0.71% |
| 06-10-2025 | $40.68 | $41.3 | $41.3665 | $40.67 | 5,087,865 | 65,585 | 1.29% |
| 06-09-2025 | $41.055 | $40.86 | $41.295 | $40.83 | 3,920,110 | 28,282 | 0.72% |
| 06-06-2025 | $41.04 | $41.2 | $41.33 | $40.96 | 3,225,597 | 26,814 | 0.83% |
| 06-05-2025 | $41.02 | $41.15 | $41.44 | $40.855 | 3,248,815 | 33,957 | 1.05% |
| 06-04-2025 | $40.54 | $40.8 | $40.96 | $40.54 | 2,939,921 | 22,103 | 0.75% |
| 06-03-2025 | $40.68 | $40.46 | $40.79 | $40.17 | 6,328,903 | 68,630 | 1.08% |
| 06-02-2025 | $41.38 | $41.66 | $41.66 | $41.03 | 4,420,011 | 20,481 | 0.46% |
| 05-30-2025 | $40.465 | $41.03 | $41.17 | $40.17 | 7,372,579 | 28,455 | 0.39% |
| 05-29-2025 | $39.26 | $40 | $40.05 | $39.22 | 5,048,296 | 61,620 | 1.22% |
| 05-28-2025 | $39.09 | $39.18 | $39.49 | $39.045 | 4,221,416 | 33,850 | 0.8% |
| 05-27-2025 | $39.535 | $39.44 | $39.65 | $39.31 | 3,511,835 | 13,622 | 0.39% |
| 05-23-2025 | $38.74 | $38.66 | $38.87 | $38.61 | 3,667,064 | 44,519 | 1.21% |
| 05-22-2025 | $38.39 | $38.92 | $39.05 | $38.305 | 5,694,387 | 26,203 | 0.46% |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
-0.21% G/L:
$38.07 Last:
8,216,399 Volume:
$38.72 Open:
$38.07 Close:
GlaxoSmithKline PLC Website:
Ad
-
Grant funding will be provided to support national, state, and local non-profit organizations and community-based groups focused on lupus New resources and tools will support implementation of community-led programs designed to improve earlier diagnosis, enhance awareness of and access to evi...
-
2025-05-28 09:54:22 ET DENVER, Colo., May 28, 2025 ( 247marketnews.com )- From sustainable biomaterials to first-in-class therapies, here’s how today’s leaders— Kraig Biocraft Laboratories, Aspire Biopharma, Spero Therapeutics, GSK, and Veru—are pushing the f...
-
2025-05-28 07:35:54 ET Potential First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections (cUTIs) DENVER, Colo., May 28, 2025 ( 247marketnews.com )- Spero Therapeutics (NASDAQ:SPRO) and GSK (NYSE:GSK) today announced that the pivotal Phase 3 PIVOT-PO trial for t...